Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Svetlana Kuleva"'
Autor:
Svetlana Kuleva, Aleksandr Druy
Publikováno v:
Problems in oncology. 66:218-222
High-grade gliomas (Grade III-IV) are aggressive brain tumor with poor prognosis. Recent investigations are aimed on pathogenic mechanisms of tumor growth on cellular at the molecular-genetic level for the development of effective individualized trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9c531331e0edaa357b1fe757b7b2d9a
https://doi.org/10.37469/0507-3758-2020-66-3-218-222
https://doi.org/10.37469/0507-3758-2020-66-3-218-222
Autor:
Aleksandr Druy, Svetlana Kuleva
Publikováno v:
Problems in oncology. 65:181-187
The recent data about innate and adaptive immunity against neuroblastoma are described in the article. The era of neuroblastoma immunotherapy started since the evidence of anti-GD2 monoclonal antibodies efficiency. Nowadays monoclonal antibodies agai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e2a89414428696d498d206dc6df58ca
https://doi.org/10.37469/0507-3758-2019-65-2-181-187
https://doi.org/10.37469/0507-3758-2019-65-2-181-187
Autor:
Svetlana Kuleva, Tatyana Semiglazova, A. Subora, Margarita Motalkina, Yevgeniya Kharchenko, Sergey Alekseev, I.V. Ishmatova Ishmatova, Yuliya Oleynik, Ilya Zyuzgin, Yuliya Chudinovskikh, Sergey Shalaev, Filatova Lv, Polina Shilo
Publikováno v:
Problems in oncology. 64:414-418
High dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT) is suggested as the standard of treatment of patients with relapsed or refractory Hodgkin’s lymphoma (HL) providing long-term disease-free survival in over 50 % of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4df59b03b607752f12c61b9ecc70e39e
https://doi.org/10.37469/0507-3758-2018-64-3-414-418
https://doi.org/10.37469/0507-3758-2018-64-3-414-418
Autor:
N. Faseeva, Svetlana Kuleva
Publikováno v:
Problems in oncology. 64:378-383
The main tumor markers of germogenic tumors are alpha-fetoprotein (AFP) and ß-subunit of human chorionic gonadotropin. The speed of normalization of tumor markers in each patient is different and its slowing is often prognostically unfavorable facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0620dddefeae093185742928b99c6593
https://doi.org/10.37469/0507-3758-2018-64-3-378-383
https://doi.org/10.37469/0507-3758-2018-64-3-378-383
Publikováno v:
Problems in oncology. 64:419-428
Despite the success of standard front-line chemotherapy for classical Hodgkin lymphoma in part of these patients relapse or resistance are developed. During last years standard therapeutic approach for relapse or refractory disease is still «salvage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfd9bdd109dbe540654d570427f3eb49
https://doi.org/10.37469/0507-3758-2018-64-3-419-428
https://doi.org/10.37469/0507-3758-2018-64-3-419-428
Publikováno v:
Problems in oncology. 63:320-325
With the use of regression and dispersion analyzes conducted in this study it was possible to identify predictive factors that significantly worsen the prognosis of Hodgkin’s lymphoma in adolescents however constructed regression equations did not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c93c89b61111db349cd9496f2f24e5b3
https://doi.org/10.37469/0507-3758-2017-63-2-320-325
https://doi.org/10.37469/0507-3758-2017-63-2-320-325